American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Berger
    Berger
  3. Schram
    Schram
  4. Drilon
    Drilon
  5. Ladanyi
    Ladanyi
  6. Bandlamudi
    Bandlamudi
  7. Stadler
    Stadler
  8. Makker
    Makker
  9. Schultz
    Schultz
  10. Chandarlapaty
    Chandarlapaty

Groups

  1. Department of Medicine (57)
  2. Early Drug Development Service (57)
  3. Solid Tumor Oncology Division (57)
  4. GSK Faculty (37)
  5. Human Oncology and Pathogenesis Program (37)
  6. Genitourinary Oncology Service (25)
  7. Breast Medicine Service (22)
  8. Gynecologic Medicine Service (22)
  9. Sloan Kettering Institute Postdocs (21)
  10. Thoracic Oncology (17)
Search Within
  1. "David Hyman"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (24)
Groups
  1. Department of Medicine (57)
  2. Early Drug Development Service (57)
  3. Solid Tumor Oncology Division (57)
  4. GSK Faculty (37)
  5. Human Oncology and Pathogenesis Program (37)
  6. Genitourinary Oncology Service (25)

More Groups

People
  1. David Hyman (57)
  2. David Solit (23)
  3. Michael Berger (20)
  4. Ahmet Zehir (14)
  5. Marc Ladanyi (14)
  6. Alison Schram (13)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (11)
  4. 2019 (21)
  5. 2018 (10)
  6. 2017 (7)

More Years

Publications
  1. Cancer Research (32)
  2. Clinical Cancer Research (25)

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Natural history and characteristics of ERBB2-mutated hormone receptor-positive metastatic breast cancer: A multi-institutional retrospective case-control study from AACR Project GENIE
    Journal Article

    LeNoue-Newton, M. L.; Chen, S. C.; Stricker, T.; Hyman, D. M.; Blauvelt, N.; Bedard, P. L.; Meric-Bernstam, F.; Punglia, R. S.; Schrag, D.; Lepisto, E. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I basket study of taselisib, an isoform-selective PI3K inhibitor, in patients with PIK3CA-mutant cancers
    Journal Article

    Jhaveri, K.; Chang, M. T.; Juric, D.; Saura, C.; Gambardella, V.; Melnyk, A.; Patel, M. R.; Ribrag, V.; Ma, C. X.; Aljumaily, R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Capivasertib, an AKT kinase inhibitor, as monotherapy or in combination with fulvestrant in patients with AKT1(E17K)-mutant, ER-positive metastatic breast cancer
    Journal Article

    Smyth, L. M.; Tamura, K.; Oliveira, M.; Ciruelos, E. M.; Mayer, I. A.; Sablin, M. P.; Biganzoli, L.; Ambrose, H. J.; Ashton, J.; Barnicle, A.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Landscape and outcome of TRK fusion-positive cancers
    Meeting Abstract

    Rosen, E. Y.; Goldman, D. A.; Hechtman, J. F.; Benayed, R.; Schram, A. M.; Cocco, E.; Shifman, S.; Gong, Y.; Kundra, R.; Solomon, J. P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Lebow, E. S.; Tu, H. Y.; Li, M.; Lim, L. P.; Arbour, K. C.; Travis, W.; Solit, D. B.; Ladanyi, M.; Jones, D. R.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic landscape of uterine sarcomas defined through prospective clinical sequencing
    Journal Article

    Hensley, M. L.; Chavan, S. S.; Solit, D. B.; Murali, R.; Soslow, R.; Chiang, S.; Jungbluth, A. A.; Bandlamudi, C.; Srinivasan, P.; Tap, W. D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: